BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15087248)

  • 1. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test.
    Cole LA; Khanlian SA
    Clin Biochem; 2004 May; 37(5):344-9. PubMed ID: 15087248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebuttal to "Easy fix for clinical laboratories for the false positive defect with Abbott AxSYM Total BhCG test" by Dr. Laurence Cole, Clin Biochem, 37(5), 344-349 (2004).
    Koziarz JJ
    Clin Biochem; 2004 Jun; 37(6):500; author reply 501. PubMed ID: 15183299
    [No Abstract]   [Full Text] [Related]  

  • 3. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the beta-Neocept test for early pregnancy.
    Yuen BH; Pride SM; Callegari PB
    Can Med Assoc J; 1984 Sep; 131(6):583-5. PubMed ID: 6206935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassay interference: a relatively rare but still important problem.
    Diamandis EP
    Clin Biochem; 2004 May; 37(5):331-2. PubMed ID: 15087246
    [No Abstract]   [Full Text] [Related]  

  • 11. Inappropriate management of women with persistent low hCG results.
    Cole LA; Khanlian SA
    J Reprod Med; 2004 Jun; 49(6):423-32. PubMed ID: 15283048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for routine detection of heterophile antibody interference in the Abbott AxSYM hCG assay.
    Jones GR; Giannopoulos P
    Pathology; 2004 Aug; 36(4):364-6. PubMed ID: 15370140
    [No Abstract]   [Full Text] [Related]  

  • 14. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma.
    Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC
    Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual cause of elevated serum total beta hCG.
    Buckner CL; Wilson L; Papadea CN
    Ann Clin Lab Sci; 2007; 37(2):186-91. PubMed ID: 17522377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
    Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
    J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample to sample carryover: a source of analytical laboratory error and its relevance to integrated clinical chemistry/immunoassay systems.
    Armbruster DA; Alexander DB
    Clin Chim Acta; 2006 Nov; 373(1-2):37-43. PubMed ID: 16777083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive pregnancy tests in a nongravid, premenopausal woman due to hCG beta-chain production by multiple myeloma.
    Slone SP; Ahmed Z; Cole LA; Elin RJ; Martin AW; Herzig RH; Herzig GP; Miller JJ
    Am J Clin Pathol; 2005 Jul; 124(1):108-12. PubMed ID: 15923168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.